Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer

Clinical Nuclear Medicine

Volumn 36, Issue 12, 2011, Pages 1102-1105

  Lin, Yansong ^a,c   Li, Tianjun ^a   Liang, Jun ^b   Li, Xiaoyi ^a   Qiu, Liheng ^a   Wang, Shasha ^a   Chen, Yonghui ^a   Kang, Zengshou ^a   Li, Fang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c NONE   (China)

Author keywords

ablation; differentiated thyroid cancer; radioiodine therapy; thyroglobulin

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ABLATION THERAPY; ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCHOOL CHILD; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; WHOLE BODY IMAGING;

EID: 80955139461     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182291c65     Document Type: Article

References (24)

1. Mihailovic J, Stefanovic L, Malesevic M. Differentiated thyroid carcinoma with distant metastases: Probability of survival and its predicting factors. Cancer Biother Radiopharm. 2007;22:250-255. (Pubitemid 46988426)
2. Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447-1463. (Pubitemid 32374886)
3. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940 -1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26:879-885. (Pubitemid 36920280)
4. Beasley NJ, Walfish PG, Witterick I, et al. Cause of death in patients with well-differentiated thyroid carcinoma. Laryngoscope. 2001;111:989-991. (Pubitemid 32523705)
5. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-142.
6. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: Prognostic factors and outcome. Clin Endocrinol (Oxf). 2005;63:87-93. (Pubitemid 40966408)
7. Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892-2899. (Pubitemid 44271732)
8. Toubert ME, Hindie E, Rampin L, et al. Distant metastases of differentiated thyroid cancer: Diagnosis, treatment and outcome. Nucl Med Rev Cent East Eur. 2007;10:106-109. (Pubitemid 351266293)
9. Sampson E, Brierley JD, Le LW, et al. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110:1451-1456. (Pubitemid 47463058)
10. Ozata M, Suzuki S, Myamoto T, et al. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab. 1994;79:98-105. (Pubitemid 24221167)
11. Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 2003;88:1433-1441. (Pubitemid 36623351)
12. Salvatori M, Raffaelli M, Castaldi P, et al. Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. Eur J Surg Oncol. 2007;33:648-654. (Pubitemid 46746545)
13. Toubeau M, Touzery C, Arveux P, et al. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med. 2004;45:988-994. (Pubitemid 47611686)
14. Makarewicz J, Adamczewski Z, Knapska-Kucharska M, et al. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery. Exp Clin Endocrinol Diabetes. 2006;114:485-489. (Pubitemid 44870896)
15. Guimaraes V, DeGroot LJ. Moderate hypothyroidism in preparation for whole body 131I scintiscans and thyroglobulin testing. Thyroid. 1996;6:69-73.
16. Spencer CA, LoPresti JS, Fatemi S, et al. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid. 1999;9:435-441. (Pubitemid 29244919)
17. Schlumberger M, Baudin E. Serum thyroglobulin determination in the follow- up of patients with differentiated thyroid carcinoma. Eur J Endocrinol. 1998;138:249-252. (Pubitemid 28154769)
18. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19: 1167-1214.
19. Shaha AR, Shah JP, Loree TR. Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg. 1997;174:474-476. (Pubitemid 27486006)
20. Suh I, Vriens MR, Guerrero MA, et al. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Am J Surg. 2010;200:41-46.
21. Giovanella L. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management. Clin Chem Lab Med. 2008;46:1067-1073.
22. Gupta M, Chia SY. Circulating thyroid cancer markers. Curr Opin Endocrinol Diabetes Obes. 2007;14:383-388. (Pubitemid 47368091)
23. Phan HT, Jager PL, van der Wal JE, et al. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation. Eur J Endocrinol. 2008;158:77-83. (Pubitemid 351211043)
24. Tourniaire J, Bernard MH, Ayzac L, et al. Serum thyroglobulin assay after total unilateral thyroid lobectomy for differentiated thyroid carcinoma-in French. Presse Med. 1990;19:1309-1312. (Pubitemid 20266630)